Results from a case-control study nested within the UK CPRD.

New research undertaken amongst almost 30,000 older adults.

Large cohort study finds older adults with a prescription had 13% lower risk.

5 strategies had differing effects on outcomes such as QoL, mood.

Deficits differ markedly from those seen with dementia.

Nearly 152 million people worldwide will have dementia by 2050.

Experts say multi-complex supplementation should not be recommended to reduce the risk of cognitive decline.

Age, amyloid burden, and tau levels differed for those experiencing subsequent decline.

Playing soccer involves several factors associated with ALS.

INTREPAD prevention trial finds pace of cognitive decline is unaffected.

Patients with dementia are not eligible under the current laws.

Meta-analysis suggests physical inactivity may play a role only in cardiometabolic disease.

Risks increased steadily with decreasing awareness about financial, other scams.

ENGAGE and EMERGE trials are being stopped for futility.